R. Pyeritz, Marfan syndrome: current and future clinical and genetic management of cardiovascular manifestations, Semin Thorac Cardiovasc Surg, vol.5, pp.11-16, 1993.

D. Judge and H. Dietz, Marfan's syndrome, The Lancet, vol.366, issue.9501, pp.1965-1976, 2005.
DOI : 10.1016/S0140-6736(05)67789-6

P. Beighton, A. De-paepe, D. Danks, G. Finidori, T. Gedde-dahl et al., International nosology of heritable disorders of connective tissue, Berlin, 1986, American Journal of Medical Genetics, vol.91, issue.3, pp.581-594, 1986.
DOI : 10.7326/0003-4819-93-6-813

H. Dietz, G. Cutting, R. Pyeritz, C. Maslen, L. Sakai et al., Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene, Nature, vol.352, issue.6333, pp.337-339, 1991.
DOI : 10.1038/352337a0

P. Handford, Fibrillin-1, a calcium binding protein of extracellular matrix, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1498, issue.2-3, pp.84-90, 2000.
DOI : 10.1016/S0167-4889(00)00085-9

L. Sakai, D. Keene, and E. Engvall, Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils, The Journal of Cell Biology, vol.103, issue.6, pp.2499-2509, 1986.
DOI : 10.1083/jcb.103.6.2499

L. Pereira, K. Andrikopoulos, J. Tian, S. Lee, D. Keene et al., Targetting of the gene encoding fibrillin???1 recapitulates the vascular aspect of Marfan syndrome, Nature Genetics, vol.266, issue.2, pp.218-222, 1997.
DOI : 10.1016/0076-6879(94)45004-8

T. Mizuguchi, G. Collod-beroud, T. Akiyama, M. Abifadel, N. Harada et al., Heterozygous TGFBR2 mutations in Marfan syndrome, Nature Genetics, vol.55, issue.8, pp.855-860, 2004.
DOI : 10.1038/nrg775

URL : https://hal.archives-ouvertes.fr/inserm-00143367

E. Neptune, P. Frischmeyer, D. Arking, L. Myers, T. Bunton et al., Dysregulation of TGF-?? activation contributes to pathogenesis in Marfan syndrome, Nature Genetics, vol.33, issue.3, pp.407-411, 2003.
DOI : 10.1038/ng1116

S. Chaudhry, S. Cain, A. Morgan, S. Dallas, and C. Shuttleworth, Fibrillin-1 regulates the bioavailability of TGF??1, The Journal of Cell Biology, vol.86, issue.3, pp.355-367, 2007.
DOI : 10.4049/jimmunol.175.7.4555

G. Collod-beroud, L. Bourdelles, S. Ades, L. Ala-kokko, L. Booms et al., polymorphism database, Human Mutation, vol.14, issue.3, pp.199-208, 2003.
DOI : 10.1002/humu.1380110112

URL : https://hal.archives-ouvertes.fr/inserm-00143263

P. Booms, J. Cisler, K. Mathews, M. Godfrey, F. Tiecke et al., Novel exon skipping mutation in the fibrillin-1 gene: Two 'hot spots' for the neonatal Marfan syndrome, Clinical Genetics, vol.42, issue.2, pp.110-117, 1999.
DOI : 10.1002/ajmg.1320420106

L. Lonnqvist, A. Child, K. Kainulainen, R. Davidson, L. Puhakka et al., A Novel Mutation of the Fibrillin Gene Causing Ectopia Lentis, Genomics, vol.19, issue.3, pp.573-576, 1994.
DOI : 10.1006/geno.1994.1110

D. Milewicz, K. Michael, N. Fisher, J. Coselli, T. Markello et al., Fibrillin-1 (FBN1) Mutations in Patients With Thoracic Aortic Aneurysms, Circulation, vol.94, issue.11, pp.2708-2711, 1996.
DOI : 10.1161/01.CIR.94.11.2708

C. Hayward, M. Porteous, and D. Brock, A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly, Molecular and Cellular Probes, vol.8, issue.4, pp.325-327, 1994.
DOI : 10.1006/mcpr.1994.1045

D. Milewicz, J. Grossfield, S. Cao, C. Kielty, W. Covitz et al., A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome., Journal of Clinical Investigation, vol.95, issue.5, pp.2373-2378, 1995.
DOI : 10.1172/JCI117930

L. Faivre, R. Gorlin, M. Wirtz, M. Godfrey, N. Dagoneau et al., In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome, Journal of Medical Genetics, vol.40, issue.1, pp.34-36, 2003.
DOI : 10.1136/jmg.40.1.34

URL : https://hal.archives-ouvertes.fr/inserm-00143439

W. Liu, C. Qian, K. Comeau, T. Brenn, H. Furthmayr et al., Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe marfan syndrome, Human Molecular Genetics, vol.5, issue.10, pp.1581-1587, 1996.
DOI : 10.1093/hmg/5.10.1581

URL : https://academic.oup.com/hmg/article-pdf/5/10/1581/1707358/5-10-1581.pdf

E. Putnam, M. Cho, A. Zinn, J. Towbin, P. Byers et al., Delineation of the Marfan phenotype associated with mutations in exons 23???32 of theFBN1 gene, American Journal of Medical Genetics, vol.346, issue.3, pp.233-242, 1996.
DOI : 10.1038/346281a0

H. Dietz and R. Pyeritz, Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders, Human Molecular Genetics, vol.4, issue.suppl_1, pp.1799-1809, 1995.
DOI : 10.1093/hmg/4.suppl_1.1799

P. Robinson, P. Booms, S. Katzke, M. Ladewig, L. Neumann et al., Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies, Human Mutation, vol.432, issue.3, pp.153-161, 2002.
DOI : 10.1161/01.CIR.94.11.2708

I. Schrijver, W. Liu, R. Odom, T. Brenn, P. Oefner et al., Premature Termination Mutations in FBN1: Distinct Effects on Differential Allelic Expression and on Protein and Clinical Phenotypes, The American Journal of Human Genetics, vol.71, issue.2, pp.223-237, 2002.
DOI : 10.1086/341581

B. Loeys, D. Backer, J. Van-acker, P. Wettinck, K. Pals et al., gene favors locus homogeneity of classical Marfan syndrome, Human Mutation, vol.14, issue.2, pp.140-146, 2004.
DOI : 10.1002/humu.20070

A. Biggin, K. Holman, M. Brett, B. Bennetts, and L. Adès, mutations in patients with Marfan syndrome or a related fibrillinopathy, Human Mutation, vol.23, issue.1, p.99, 2004.
DOI : 10.1002/humu.9207

E. Arbustini, M. Grasso, S. Ansaldi, C. Malattia, A. Pilotto et al., Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies, Human Mutation, vol.26, issue.5, p.494, 2005.
DOI : 10.1002/humu.9377

K. Rommel, M. Karck, A. Haverich, Y. Von-kodolitsch, M. Rybczynski et al., Identification of 29 novel and nine recurrent fibrillin-1 (FBN1) mutations and genotype-phenotype correlations in 76 patients with Marfan syndrome, Human Mutation, vol.316, issue.6, pp.529-539, 2005.
DOI : 10.1179/acb.2003.58.1.001

M. Shapiro and P. Senapathy, RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression, Nucleic Acids Research, vol.15, issue.17, pp.7155-7174, 1987.
DOI : 10.1093/nar/15.17.7155

P. Senapathy, M. Shapiro, and N. Harris, [16] Splice junctions, branch point sites, and exons: Sequence statistics, identification, and applications to genome project, Methods Enzymol, vol.183, pp.252-278, 1990.
DOI : 10.1016/0076-6879(90)83018-5

C. Beroud, D. Hamroun, G. Collod-beroud, C. Boileau, T. Soussi et al., UMD (Universal Mutation Database): 2005 update, ): 2005 update, pp.184-191, 2005.
DOI : 10.1002/humu.20210

URL : https://hal.archives-ouvertes.fr/inserm-00143605

A. Downing, V. Knott, J. Werner, C. Cardy, I. Campbell et al., Solution Structure of a Pair of Calcium-Binding Epidermal Growth Factor-like Domains: Implications for the Marfan Syndrome and Other Genetic Disorders, Cell, vol.85, issue.4, pp.597-605, 1996.
DOI : 10.1016/S0092-8674(00)81259-3

P. Ng and S. Henikoff, Predicting Deleterious Amino Acid Substitutions, Genome Research, vol.11, issue.5, pp.863-874, 2001.
DOI : 10.1101/gr.176601

URL : http://genome.cshlp.org/content/11/5/863.full.pdf

P. Ng and S. Henikoff, SIFT: predicting amino acid changes that affect protein function, Nucleic Acids Research, vol.31, issue.13, pp.3812-3814, 2003.
DOI : 10.1093/nar/gkg509

URL : https://academic.oup.com/nar/article-pdf/31/13/3812/9487105/gkg509.pdf

S. Henikoff and J. Henikoff, Amino acid substitution matrices from protein blocks., Proceedings of the National Academy of Sciences, vol.89, issue.22, pp.10915-10919, 1992.
DOI : 10.1073/pnas.89.22.10915

URL : http://www.pnas.org/content/89/22/10915.full.pdf

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-481, 1958.
DOI : 10.1214/aoms/1177731566

N. Mantel and W. Haenszel, Statistical aspects of the analysis of data from retrospective studies of disease, J Natl Cancer Inst, vol.22, pp.719-748, 1959.

N. Breslow and N. Day, Statistical methods in cancer research: the design and analyses of cohort studies, International Agency for Research on Cancer Scientific Publications, vol.2, 1987.

H. Dietz, I. Mcintosh, L. Sakai, G. Corson, S. Chalberg et al., Four Novel FBN1 Mutations: Significance for Mutant Transcript Level and EGF-like Domain Calcium Binding in the Pathogenesis of Marfan Syndrome, Genomics, vol.17, issue.2, pp.468-475, 1993.
DOI : 10.1006/geno.1993.1349

Z. Eldadah, T. Brenn, H. Furthmayr, and H. Dietz, Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype., Journal of Clinical Investigation, vol.95, issue.2, pp.874-880, 1995.
DOI : 10.1172/JCI117737

D. Judge, N. Biery, D. Keene, J. Geubtner, L. Myers et al., Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome, Journal of Clinical Investigation, vol.114, issue.2, pp.172-181, 2004.
DOI : 10.1172/JCI200420641

P. Whiteman and P. Handford, Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders, Human Molecular Genetics, vol.12, issue.7, pp.727-737, 2003.
DOI : 10.1093/hmg/ddg081

I. Schrijver, W. Liu, T. Brenn, H. Furthmayr, and U. Francke, Cysteine Substitutions in Epidermal Growth Factor???Like Domains of Fibrillin-1: Distinct Effects on Biochemical and Clinical Phenotypes, The American Journal of Human Genetics, vol.65, issue.4, pp.1007-1020, 1999.
DOI : 10.1086/302582

B. Loeys, U. Schwarze, T. Holm, B. Callewaert, G. Thomas et al., Aneurysm Syndromes Caused by Mutations in the TGF-?? Receptor, New England Journal of Medicine, vol.355, issue.8, pp.788-798, 2006.
DOI : 10.1056/NEJMoa055695

A. Nemet, E. Assia, D. Apple, and I. Barequet, Current Concepts of Ocular Manifestations in Marfan Syndrome, Survey of Ophthalmology, vol.51, issue.6, pp.561-575, 2006.
DOI : 10.1016/j.survophthal.2006.08.008

L. Lönnqvist, L. Karttunen, T. Rantamäki, C. Kielty, M. Raghunath et al., A Point Mutation Creating an ExtraN-Glycosylation Site in Fibrillin-1 Results in Neonatal Marfan Syndrome, Genomics, vol.36, issue.3, pp.468-475, 1996.
DOI : 10.1006/geno.1996.0492

S. Katzke, P. Booms, F. Tiecke, M. Palz, A. Pletschacher et al., coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies, Human Mutation, vol.16, issue.3, pp.197-208, 2002.
DOI : 10.1161/01.CIR.103.20.2469

J. Korkko, I. Kaitila, L. Lonnqvist, L. Peltonen, and L. Ala-kokko, Sensitivity of conformation sensitive gel electrophoresis in detecting mutations in Marfan syndrome and related conditions, Journal of Medical Genetics, vol.39, issue.1, pp.34-41, 2002.
DOI : 10.1136/jmg.39.1.34

B. Loeys, L. Nuytinck, I. Delvaux, D. Bie, S. et al., Genotype and Phenotype Analysis of 171 Patients Referred for Molecular Study of the Fibrillin-1 Gene FBN1 Because of Suspected Marfan Syndrome, Archives of Internal Medicine, vol.161, issue.20, pp.2447-2454, 2001.
DOI : 10.1001/archinte.161.20.2447

S. Hutchinson, A. Furger, D. Halliday, D. Judge, A. Jefferson et al., Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?, Human Molecular Genetics, vol.12, issue.18, pp.2269-2276, 2003.
DOI : 10.1093/hmg/ddg241